Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $94.19 | $22.95 | 310.40% | 204.76x | 161.45x | 12.79x | 15.85x | 1.46x | $119.79M | 1.22% | $637.99M | 6.11 | $10.01B | -1,458.25 | ||
| LQDA | LIQUIDIA CORP | $86.82 | $17.08 | 408.40% | 361.75x | 26.13x | 26.53x | 71.11x | 1.75x | $41.15M | 0.54% | $108.58M | 1.23 | $7.68B | 143.35 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $79.44 | $16.29 | 387.64% | 81.06x | 63.10x | 8.06x | 10.09x | 2.24x | $164.23M | 2.70% | $605.69M | 7.92 | $5.93B | 53.20 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $288.41 | $89.64 | 221.73% | 66.15x | 39.81x | 8.94x | 35.81x | 1.36x | $641.34M | 1.67% | $1.08B | 8.09 | $39.77B | 43.01 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.24 | $2.69 | 206.54% | 117.71x | 73.44x | 4.46x | 109.34x | 1.13x | $47.52M | 3.39% | $13.01M | 0.08 | $1.57B | 29.37 | ||
| HALO | HALOZYME THERAPEUTICS INC | $83.45 | $67.80 | 23.07% | 28.19x | 10.05x | 6.54x | 45.06x | 0.50x | $667.65M | 6.77% | $219.64M | 1.86 | $11.73B | 18.80 | ||
| ASND | ASCENDIS PHARMA A | $254.44 | $76.32 | 233.39% | 26.97x | 17.49x | 15.52x | 27.53x | 2.81x | $52.94M | 0.33% | $574.09M | 9.24 | $16.18B | 173.55 | ||
| RPRX | ROYALTY PHARMA PLC | $59.97 | $38.69 | 55.01% | 31.40x | 11.18x | 10.73x | 3.48x | 0.66x | $2.34B | 8.94% | $9.94B | 22.75 | $42.90B | 36.88 | ||
| ADMA | ADMA BIOLOGICS INC | $8.79 | $8.77 | 0.28% | 12.74x | 10.48x | 4.07x | 5.22x | 0.53x | $107.90M | 5.20% | $390.33M | 1.65 | $2.10B | 9.47 | ||
| KRYS | KRYSTAL BIOTECH INC | $364.23 | $87.36 | 316.94% | 47.00x | 47.76x | 25.56x | 8.41x | 2.41x | $237.38M | 2.23% | $1.28B | 43.59 | $10.25B | 47.88 | ||
| VCEL | VERICEL CORP | $46.71 | $8.70 | 436.72% | 108.63x | 96.89x | 8.12x | 6.70x | 2.28x | $47.49M | 2.00% | $356.23M | 7.02 | $2.37B | 58.65 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $62.07 | $37.38 | 66.04% | 44.34x | 16.71x | 3.69x | 1.93x | 0.65x | $767.06M | 6.42% | $6.21B | 32.27 | $10.36B | 21.46 | ||
| TGTX | TG THERAPEUTICS INC | $54.87 | $23.32 | 135.34% | 17.04x | 38.94x | 11.32x | 14.40x | 2.45x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.71B | 58.05 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $256.92 | $46.94 | 447.32% | 546.64x | 9.95x | 3.58x | 3.56x | 1.84x | $1.30B | 8.16% | $4.53B | 73.22 | $19.68B | 29.15 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $35.77 | $33.50 | 6.78% | 14.14x | 9.42x | 2.30x | 2.27x | 0.55x | $341.79M | 16.53% | $910.35M | 15.75 | $1.64B | 6.92 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $296.28 | $97.48 | 203.93% | 37.50x | 32.06x | 21.46x | 5.95x | 1.64x | $122.22M | 2.07% | $997.32M | 50.16 | $6.27B | 27.82 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.20 | $8.55 | -86.03% | 4.43x | -4.04x | 1.12x | 1.31x | 0.05x | $7.24M | 10.54% | $52.93M | 0.92 | $15.54M | 1.00 | ||
| TECH | BIO-TECHNE CORP | $72.07 | $15.95 | 351.71% | 101.51x | 34.54x | 9.31x | 5.41x | 1.86x | $269.60M | 2.39% | $2.09B | 13.34 | $11.36B | 44.40 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $490.39 | $158.05 | 210.27% | 28.83x | 25.36x | 10.20x | 6.43x | 2.16x | $3.71B | 2.98% | $19.36B | 76.20 | $120.96B | 22.43 | ||
| EXEL | EXELIXIS INC | $56.51 | $28.95 | 95.22% | 18.11x | 17.56x | 6.15x | 7.34x | 1.36x | $917.69M | 6.29% | $1.94B | 7.49 | $14.15B | 13.40 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.29 | $1.96 | 68.21% | 13.71x | 14.23x | 2.02x | 3.18x | 1.40x | $4.11M | 1.55% | $82.33M | 1.03 | $198.06M | 9.32 | ||
| UTHR | UNITED THERAPEUTICS CORP | $523.63 | $227.38 | 130.29% | 17.88x | 19.13x | 7.19x | 3.77x | 2.08x | $1.02B | 4.46% | $5.90B | 135.66 | $20.95B | 12.22 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $695.18 | $413.44 | 68.15% | 16.33x | 14.89x | 4.85x | 2.32x | 1.11x | $4.11B | 5.69% | $31.42B | 302.15 | $72.63B | 12.64 | ||
| INCY | INCYTE CORP | $129.93 | $63.21 | 105.55% | 17.82x | 17.09x | 4.83x | 4.62x | 1.56x | $1.45B | 5.60% | $5.62B | 28.21 | $22.53B | 12.04 | ||
| VCYT | VERACYTE INC | $55.65 | $8.59 | 547.98% | 50.14x | 50.18x | 8.17x | 3.30x | 5.90x | $155.34M | 3.51% | $1.34B | 16.90 | $4.22B | 36.64 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.